Halozyme Therapeutics shares owned by Harbor Capital Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Harbor Capital Advisors
from 13F filings
Historical chart of Harbor Capital Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Harbor Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Harbor Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $2.0M | 31k | 64.61 |
| 2025-06-30 | $16k | 309 | 51.78 |
| 2025-03-31 | $21k | 336 | 62.50 |
| 2024-12-31 | $12k | 244 | 49.18 |
| 2024-09-30 | $13k | 231 | 56.28 |